449 related articles for article (PubMed ID: 24549332)
1. Selective anticancer copper(II)-mixed ligand complexes: targeting of ROS and proteasomes.
Ng CH; Kong SM; Tiong YL; Maah MJ; Sukram N; Ahmad M; Khoo AS
Metallomics; 2014 Apr; 6(4):892-906. PubMed ID: 24549332
[TBL] [Abstract][Full Text] [Related]
2. Biological and cytoselective anticancer properties of copper(II)-polypyridyl complexes modulated by auxiliary methylated glycine ligand.
Seng HL; Wang WS; Kong SM; Alan Ong HK; Win YF; Raja Abd Rahman RN; Chikira M; Leong WK; Ahmad M; Khoo AS; Ng CH
Biometals; 2012 Oct; 25(5):1061-81. PubMed ID: 22836829
[TBL] [Abstract][Full Text] [Related]
3. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor mechanisms of a copper(II) complex of anthracene-9-imidazoline hydrazone (9-AIH).
Qin QP; Liu YC; Wang HL; Qin JL; Cheng FJ; Tang SF; Liang H
Metallomics; 2015 Jul; 7(7):1124-36. PubMed ID: 25904543
[TBL] [Abstract][Full Text] [Related]
5. Ternary copper(II)-polypyridyl enantiomers: aldol-type condensation, characterization, DNA-binding recognition, BSA-binding and anticancer property.
Ng CH; Wang WS; Chong KV; Win YF; Neo KE; Lee HB; San SL; Raja Abd Rahman RN; Leong WK
Dalton Trans; 2013 Jul; 42(28):10233-43. PubMed ID: 23728518
[TBL] [Abstract][Full Text] [Related]
6. Efficient hydrolytic cleavage of DNA and antiproliferative effect on human cancer cells by two dinuclear Cu(II) complexes containing a carbohydrazone ligand and 1,10-phenanthroline as a coligand.
Parsekar SU; Singh M; Mishra DP; Antharjanam PKS; Koley AP; Kumar M
J Biol Inorg Chem; 2019 May; 24(3):343-363. PubMed ID: 30887122
[TBL] [Abstract][Full Text] [Related]
7. Novel copper complexes as potential proteasome inhibitors for cancer treatment (Review).
Zhang Z; Wang H; Yan M; Wang H; Zhang C
Mol Med Rep; 2017 Jan; 15(1):3-11. PubMed ID: 27959411
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, DNA binding, cellular DNA lesion and cytotoxicity of a series of new benzimidazole-based Schiff base copper(II) complexes.
Paul A; Anbu S; Sharma G; Kuznetsov ML; Koch B; Guedes da Silva MF; Pombeiro AJ
Dalton Trans; 2015 Dec; 44(46):19983-96. PubMed ID: 26523453
[TBL] [Abstract][Full Text] [Related]
9. Vanadium(IV) and copper(II) complexes of salicylaldimines and aromatic heterocycles: Cytotoxicity, DNA binding and DNA cleavage properties.
Correia I; Roy S; Matos CP; Borovic S; Butenko N; Cavaco I; Marques F; Lorenzo J; Rodríguez A; Moreno V; Pessoa JC
J Inorg Biochem; 2015 Jun; 147():134-46. PubMed ID: 25858461
[TBL] [Abstract][Full Text] [Related]
10. Copper(II) Complexes Containing Natural Flavonoid Pomiferin Show Considerable In Vitro Cytotoxicity and Anti-inflammatory Effects.
Vančo J; Trávníček Z; Hošek J; Malina T; Dvořák Z
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299247
[TBL] [Abstract][Full Text] [Related]
11. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper compounds for the treatment of cancer.
Iglesias S; Alvarez N; Torre MH; Kremer E; Ellena J; Ribeiro RR; Barroso RP; Costa-Filho AJ; Kramer MG; Facchin G
J Inorg Biochem; 2014 Oct; 139():117-23. PubMed ID: 25033418
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear Cu(I) complexes of pyridyl-diazadiphosphetidines and aminobis(phosphonite) ligands: synthesis, structural studies and antiproliferative activity towards human cervical, colon carcinoma and breast cancer cells.
Rashid A; Ananthnag GS; Naik S; Mague JT; Panda D; Balakrishna MS
Dalton Trans; 2014 Aug; 43(29):11339-51. PubMed ID: 24922341
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) mixed chelate compounds induce apoptosis through reactive oxygen species in neuroblastoma cell line CHP-212.
Gutiérrez AG; Vázquez-Aguirre A; García-Ramos JC; Flores-Alamo M; Hernández-Lemus E; Ruiz-Azuara L; Mejía C
J Inorg Biochem; 2013 Sep; 126():17-25. PubMed ID: 23727332
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
[TBL] [Abstract][Full Text] [Related]
16. Anticancer activity of a new copper(II) complex with a hydrazone ligand. Structural and spectroscopic characterization, computational simulations and cell mechanistic studies on 2D and 3D breast cancer cell models.
Balsa LM; Ferraresi-Curotto V; Lavecchia MJ; Echeverría GA; Piro OE; García-Tojal J; Pis-Diez R; González-Baró AC; León IE
Dalton Trans; 2021 Jul; 50(28):9812-9826. PubMed ID: 34190268
[TBL] [Abstract][Full Text] [Related]
17. Ternary copper(II) complexes with amino acid chains and heterocyclic bases: DNA binding, cytotoxic and cell apoptosis induction properties.
Ma T; Xu J; Wang Y; Yu H; Yang Y; Liu Y; Ding W; Zhu W; Chen R; Ge Z; Tan Y; Jia L; Zhu T
J Inorg Biochem; 2015 Mar; 144():38-46. PubMed ID: 25555321
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative Activities of Diimine-Based Mixed Ligand Copper(II) Complexes.
Kordestani N; Rudbari HA; Fernandes AR; Raposo LR; Baptista PV; Ferreira D; Bruno G; Bella G; Scopelliti R; Braun JD; Herbert DE; Blacque O
ACS Comb Sci; 2020 Feb; 22(2):89-99. PubMed ID: 31913012
[TBL] [Abstract][Full Text] [Related]
19. Cu(II) complexes with co-planar [Cu(II)(N-N)(HIMC⁻)], their anti-cancer activities, ΔG, ΔE and solid luminescence.
Cheng YF; Lu XM; Wang G
Dalton Trans; 2014 Apr; 43(14):5357-63. PubMed ID: 24519174
[TBL] [Abstract][Full Text] [Related]
20. Mixed-ligand Cu(II) hydrazone complexes designed to enhance anticancer activity.
Mo Q; Deng J; Liu Y; Huang G; Li Z; Yu P; Gou Y; Yang F
Eur J Med Chem; 2018 Aug; 156():368-380. PubMed ID: 30015073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
